McCulloch MW et al. |
Psammaplin A as a general activator of cell-based signaling assays via HDAC inhibition and studies on some bromotyrosine derivatives. |
2009 |
Bioorg. Med. Chem. |
pmid:19022675
|
Fu J et al. |
Discovery of 1H-benzo[d][1,2,3]triazol-1-yl 3,4,5-trimethoxybenzoate as a potential antiproliferative agent by inhibiting histone deacetylase. |
2010 |
Bioorg. Med. Chem. |
pmid:21067930
|
Patil V et al. |
Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group. |
2010 |
Bioorg. Med. Chem. |
pmid:19914074
|
Nishino N et al. |
Interaction of aliphatic cap group in inhibition of histone deacetylases by cyclic tetrapeptides. |
2008 |
Bioorg. Med. Chem. |
pmid:17900911
|
Estiu G et al. |
On the inhibition of histone deacetylase 8. |
2010 |
Bioorg. Med. Chem. |
pmid:20472442
|
Kaldre D et al. |
Optimization of histone deacetylase inhibitor activity in non-secosteroidal vitamin D-receptor agonist hybrids. |
2015 |
Bioorg. Med. Chem. |
pmid:26048026
|
Kiyokawa S et al. |
New orally bioavailable 2-aminobenzamide-type histone deacetylase inhibitor possessing a (2-hydroxyethyl)(4-(thiophen-2-yl)benzyl)amino group. |
2010 |
Bioorg. Med. Chem. |
pmid:20452226
|
Nishino N et al. |
Synthesis and histone deacetylase inhibitory activity of cyclic tetrapeptides containing a retrohydroxamate as zinc ligand. |
2004 |
Bioorg. Med. Chem. Lett. |
pmid:15109626
|
Marson CM et al. |
Stereodefined and polyunsaturated inhibitors of histone deacetylase based on (2E,4E)-5-arylpenta-2,4-dienoic acid hydroxyamides. |
2004 |
Bioorg. Med. Chem. Lett. |
pmid:15109636
|
Hoque MA et al. |
Cyclic tetrapeptides with thioacetate tails or intramolecular disulfide bridge as potent inhibitors of histone deacetylases. |
2012 |
Bioorg. Med. Chem. Lett. |
pmid:23021104
|
Krennhrubec K et al. |
Design and evaluation of 'Linkerless' hydroxamic acids as selective HDAC8 inhibitors. |
2007 |
Bioorg. Med. Chem. Lett. |
pmid:17346959
|
Rajak H et al. |
2,5-Disubstituted-1,3,4-oxadiazoles/thiadiazole as surface recognition moiety: design and synthesis of novel hydroxamic acid based histone deacetylase inhibitors. |
2011 |
Bioorg. Med. Chem. Lett. |
pmid:21875796
|
Vaidya AS et al. |
Novel histone deacetylase 8 ligands without a zinc chelating group: exploring an 'upside-down' binding pose. |
2012 |
Bioorg. Med. Chem. Lett. |
pmid:23010266
|
Smil DV et al. |
Novel HDAC6 isoform selective chiral small molecule histone deacetylase inhibitors. |
2009 |
Bioorg. Med. Chem. Lett. |
pmid:19111466
|
Islam NM et al. |
Bicyclic peptides as potent inhibitors of histone deacetylases: optimization of alkyl loop length. |
2010 |
Bioorg. Med. Chem. Lett. |
pmid:20045316
|
Hooven LA et al. |
Effects of suberoylanilide hydroxamic acid and trichostatin A on induction of cytochrome P450 enzymes and benzo[a]pyrene DNA adduct formation in human cells. |
2005 |
Bioorg. Med. Chem. Lett. |
pmid:15713371
|
Chen B et al. |
Chemistry and biology of mercaptoacetamides as novel histone deacetylase inhibitors. |
2005 |
Bioorg. Med. Chem. Lett. |
pmid:15713393
|
Choi E et al. |
Structure and property based design, synthesis and biological evaluation of γ-lactam based HDAC inhibitors. |
2011 |
Bioorg. Med. Chem. Lett. |
pmid:21256006
|
Nakao Y et al. |
Evaluation of antiangiogenic activity of azumamides by the in vitro vascular organization model using mouse induced pluripotent stem (iPS) cells. |
2008 |
Bioorg. Med. Chem. Lett. |
pmid:18397826
|
Mazitschek R et al. |
Development of a fluorescence polarization based assay for histone deacetylase ligand discovery. |
2008 |
Bioorg. Med. Chem. Lett. |
pmid:18430569
|